Novotech Health Holdings Appoints Zidong Zhang as CFO

SHANGHAI and SYDNEY, Dec. 28, 2020 /PRNewswire/ — Novotech Well being Holdings (“Novotech Holdings”), the most important biotech specialist contract analysis group (CRO) in Asia, right this moment introduced the appointment of Zidong Zhang as Chief Monetary Officer (CFO) efficient four January 2021. Zidong Zhang shall be chargeable for all features of monetary administration and work intently with Novotech Holdings’ govt group to help the expansion of the enterprise throughout Asia.

Dr. Zhang was most lately CFO at Henlius Biotech, a Hong Kong-listed world biopharmaceutical firm based mostly in Shanghai, the place he constructed and managed the finance group and performed an integral function within the firm’s preliminary public providing in 2019. Previous to that, Dr. Zhang was an fairness analysis analyst at UBS in New York, the place he lined the Main and Specialty Pharmaceutical Sector. He additionally beforehand served as Senior Guide for Bayer A.G. in its healthcare observe and performed postdoctoral analysis in diabetes-related drug growth at Boston College’s Faculty of Drugs. Dr. Zhang holds a PhD in Biochemistry from Boston College, an MBA from Duke College, and a BS in Chemistry from Fudan College.

Joel Thickins, Chairman of Novotech Holdings and TPG Capital Asia’s Head of Australia and New Zealand, stated, “With a various background in monetary administration, capital markets transactions, healthcare analysis and consulting, Zidong Zhang has a novel mixture of expertise and expertise which are effectively suited to our development ambitions. Zidong will additional bolster Novotech’s management group and assist to facilitate our enlargement all through Asia.”

John Moller, CEO of Novotech Holdings stated, “Zidong’s intensive expertise in biotech and healthcare, coupled together with his monetary experience from his roles at UBS and Henlius Biotech shall be invaluable as we enter the subsequent part of development for our enterprise. We sit up for welcoming Zidong to the group.” 

Zidong Zhang stated, “The biotech sector in Asia continues to be in its infancy and there shall be vital development in demand for high quality medical trial providers because the sector develops. Becoming a member of Novotech Holdings is an thrilling alternative to work with a extremely dedicated {and professional} group to ship a robust development technique as we assist our purchasers to develop the subsequent technology of progressive medicine.”

ABOUT NOVOTECH HEALTH HOLDINGS

Novotech Well being Holdings (“Novotech Holdings”) is the main Asian biotech CRO and consists of two working manufacturers, Novotech and PPC. Novotech Holdings is a full-service CRO with built-in labs and part I services offering drug growth consulting and medical growth providers. It has been instrumental within the success of roughly 3,700 medical trials throughout all trial phases and therapeutic areas. Novotech Holdings is uniquely positioned to serve biopharmaceutical purchasers conducting medical trials in Asia and globally. Novotech Holdings employs roughly 1,550 folks in 21 places of work throughout 12 geographies together with Better China, South Korea, South East Asia, India and ANZ. Novotech Holdings is majority owned by TPG Capital Asia funds.

ABOUT TPG

TPG is a number one world various asset agency based in 1992 with roughly $85 billion of property underneath administration and places of work in Austin, Beijing, Fort Value, Hong Kong, London, Luxembourg, Melbourne, Moscow, Mumbai, New York, San Francisco, Seoul, Singapore, and Washington, DC. TPG’s funding platforms are throughout a variety of asset lessons, together with non-public fairness, development fairness, affect investing, actual property, and public fairness. TPG goals to construct dynamic merchandise and choices for its traders whereas additionally instituting self-discipline and operational excellence throughout the funding technique and efficiency of its portfolio. For extra data, go to www.tpg.com on Twitter @TPG.

SOURCE Novotech Well being Holdings

— to www.prnewswire.com

The post Novotech Health Holdings Appoints Zidong Zhang as CFO appeared first on Correct Success.

source https://correctsuccess.com/financial-management/novotech-health-holdings-appoints-zidong-zhang-as-cfo/